3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
beta-Thalassemia
1
Myelodysplastic Syndromes
1
Anemia
1
Interventions
luspatercept
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
beta-Thalassemia
×
luspatercept
×
Clear all
NCT02604433
2023-04-18
BELIEVE
Celgene
Phase 3
Completed
336 enrolled
38 charts
1 FDA